Skip to main content
. 2021 Jun 29;2021(6):CD014693. doi: 10.1002/14651858.CD014693
Study characteristics Description stated in report Location in text
Country    
Single centre/ Multicentre    
Setting (including location and social context)    
Population (from which study participants are drawn)    
Number of participants randomised to each group    
Number of withdrawals and dropouts after randomisation    
Number of participants analysed in each group    
Interventions    
The name of drug used in the experimental group    
The type of drug used in the control group    
Intermittent or continuous administration?    
Dose/ frequency of administration    
Duration of treatment (days/ hours)    
The timing when the paralysis initiated    
Target depth of paralysis    
Other treatment received (additional intervention)    
Follow‐up period